High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, Guizhi Yang et al.|Nature Medicine|2015Cited by 1.4k
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR lossHuayang Liu, E. Robert McDonald, Javad Golji et al.|Nature Medicine|2018Cited by 369
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast CancerRobert M. Witwicki, Kornélia Polyák, Muhammad B. Ekram et al.|Cell Reports|2018Cited by 78
In-Depth Characterization and Validation in <i>BRG1</i> -Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin RemodelingZainab Jagani, Margaret E. McLaughlin, Gregg Chenail et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 9